Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Base Year
Historical Year
Forecast Year
The global ethosuximide market is expected to grow at a CAGR of 4% during the forecast period of 2024-2032, driven by the increasing prevalence of absence seizure, rising availability of generic versions of ethosuximide medication, and the growing focus on pediatric and adolescent epilepsy across the globe.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Ethosuximide is a medication used in the treatment of absence seizures. Absence seizures are characterized by a brief, sudden lapse of consciousness. It is commonly sold under the brand name Zarontin. The market for ethosuximide is driven by the increasing number of patients suffering from absence seizures. The market demand is also bolstered by the rising availability of generic versions of ethosuximide, which are typically more affordable and thus accessible to a larger patient population. The increasing investments in research and development by the government are anticipated to aid the market expansion. The rising investments in healthcare infrastructure in emerging markets, such as Asia Pacific and Latin America, are likely to increase market demand in the forecast period. Moreover, increasing health consciousness and improved living standards are expected to boost the market growth in the forecast period.
Increasing Prevalence of Absence Seizures to Drive Market Growth
Absence seizures occur in multiple genetic generalized epilepsies such as childhood absence epilepsy (CAE), juvenile myoclonic epilepsy (JME), and juvenile absence epilepsy (JAE). This condition usually affects children aged 5 to 15 years. Childhood absence epilepsy is considered a common pediatric epilepsy syndrome, with the incidence reported to be around 6.3 to 8.0 children per 100,000 individuals annually. Moreover, 10% to 17% of cases of epilepsy in school-aged children are a result of childhood absence epilepsy. Since ethosuximide is prescribed as the first-line treatment for absence epilepsy, the market demand is anticipated to witness a surge with the rising cases of absence seizures.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The market is witnessing several trends and developments to improve the current global scenario. Some of the notable trends are as follows:
Growth in R&D Activities to Affect the Market Landscape
Pharmaceutical companies and research institutions are making significant investments to explore new indications and combination therapies involving ethosuximide. Further, increased research into novel drug delivery systems and formulations, such as extended-release or oral-dispersible forms, is anticipated to augment the market demand. Moreover, the rise in the number of clinical trials assessing the long-term safety and tolerability of the drug is set to impact the market dynamics.
Rising Availability of Generic Ethosuximide to Boost Ethosuximide Market Demand
One of the major market trends is the rising availability and acceptance of generic versions of ethosuximide. For example, Ethosuximide Softgel Capsules USP, 250 mg, developed by Strides Pharma Global, was approved by the United States Food and Drug Administration (FDA) as a generic equivalent of Pfizer’s Zarontin (250 mg) Capsules. Thus, the increased generic penetration is expected to offer cost-effective treatment options, which is likely to aid in market expansion.
Government and Healthcare Initiatives Set to Boost Market Size
The rise in the supportive policies and programs implemented by the governments to promote epilepsy treatment is a major trend that is projected to boost the market size. Such initiatives strive to make medications more accessible and affordable, which ultimately propels market growth. Additionally, the growing healthcare coverage is set to increase patient access to ethosuximide.
Increased Focus on Pediatric and Adolescent Epilepsy to Elevate the Ethosuximide Market Value
The market is experiencing a growing focus on developing specialized treatments for pediatric and adolescent epilepsy patients. This is leading to the development of ethosuximide formulations, such as liquid or dissolvable forms of the drug, that can help to provide accurate and flexible dosing while also keeping the ease of administration in consideration. Further, the growth in the number of clinical trials designed to evaluate the efficacy and safety of ethosuximide in pediatric and adolescent populations is poised to influence the market dynamics.
Market Breakup by Form
Market Breakup by End User
Market Breakup by Region
Market Segmentation Based on Form is Anticipated to Witness Substantial Growth
The market segmentation by form includes the oral solution and capsules. The oral solution form of ethosuximide is generally used by pediatric and geriatric patients who may find it difficult to swallow capsules. This segment, which includes ethosuximide in the liquid form, is also preferred for children due to the ease of administration. On the other hand, ethosuximide capsules are preferred by adult patients who can easily swallow pills. Capsules have a longer shelf life compared to liquid forms, and thus experience significant demand in the market. The capsule form is also easy to carry and consume and is convenient for patients with active lifestyles.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Based on the region, North America represents a major market for ethosuximide due to a significant number of patients with absence seizures which drives the demand for the medication. In the United States, Parke-Davis (a division of Pfizer) markets Zarontin (ethosuximide), which is used to treat childhood and juvenile absence epilepsy, absence seizures, and atypical absence seizures. Besides the presence of key market players in the region, the market in North America also benefits from the advanced healthcare infrastructure and access to specialized care, which contributes to the increased demand of the drug.
The Asia Pacific region is also expected to hold a high market value supported by the increasing diagnosis rates and rising investments in healthcare infrastructure. Moreover, the growing prevalence of epilepsy and increasing awareness about epilepsy treatment is likely to fuel the market growth in the region.
The key features of the market report comprise the patent analysis, funding and investment analysis, and strategic initiatives by the leading key players. The major companies in the market are as follows:
GL Pharma
Austrian pharmaceutical company GL Pharma specializes in manufacturing and distributing a range of medications, including ethosuximide. The company is known for its Petinimid® soft capsules Package Leaflet , which contains ethosuximide as the active component.
PAI Pharma
PAI Pharma is another key player in the ethosuximide market and is focused on ensuring quality control in its manufacturing processes to produce reliable and effective medications. The company is engaged in building strong partnerships with distributors and healthcare providers to boost its market reach.
Pfizer Inc.
Pfizer Inc. is a major player in the market, leveraging its robust distribution network to serve its huge customer base. The company sells Zarontin®(Ethosuximide) Oral Solution , with the optimal dose indicated to be 20 mg/kg/day for pediatric patients. Pfizer also invests heavily in R&D to improve the formulation of ethosuximide.
Strides Pharma Science Limited
Indian pharmaceutical company Strides Pharma Science has a prominent presence in the market, recognized for manufacturing high-quality generic medications. Its generic drug Ethosuximide Softgel Capsules USP, 250 mg is available in the United States.
Other key players in the market include Biopharma, SGPharma Pvt. Ltd., and SimSon Pharma Limited, among others.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Form |
|
Breakup by End User |
|
Breakup by Region |
|
Market Dynamics |
|
Supplier Landscape |
|
Companies Covered |
|
Ethosuximide Market Regional Analysis
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us today for customized, data-driven solutions tailored to your unique requirements!
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Pricing Plans
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124